Author:
Dong Yanzhao,Alhaskawi Ahmad,Zou Xiaodi,Zhou Haiying,Ezzi Sohaib Hasan Abdullah,Kota Vishnu Goutham,Abdulla Mohamed Hasan Abdulla Hasan,Olga Alenikova,Abdalbary Sahar Ahmed,Lu Hui
Abstract
AbstractCat scratch disease (CSD) is caused by Bartonella henselae (B. henselae) and presents as lymphadenopathy following close contact with cats. However, in context of the global COVID-19 pandemic, clinical manifestations of CSD may vary, posing new challenges for healthcare professionals. Here we describe a case of a 54-year-old male with painful left upper arm mass, which gradually resolved until he was infected with COVID-19. The mass then rapidly progressed before admission. Meanwhile, pulmonary symptoms including pleural effusion emerged simultaneously. The cause was undetermined with routine blood culture and pathological test until the next generation sequencing (NGS) confirmed the presence of B. henselae. We believe this case is the first to report localized aggravation of CSD after COVID-19 infection and hopefully, offers treatment experience for clinicians worldwide.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics. 2008;121(5):e1413–25.
2. Peng J, Fan Z, Zheng H, Lu J, Zhan Y. Combined application of immunohistochemistry and Warthin-starry silver stain on the pathologic diagnosis of cat scratch disease. Appl Immunohistochem Mol Morphol. 2020;28(10):781–5.
3. Klotz SA, Ianas V, Elliott SP. Cat-scratch disease. Am Fam Physician. 2011;83(2):152–5.
4. Windsor JJ. Cat-scratch disease: epidemiology, aetiology and treatment. Br J Biomed Sci. 2001;58(2):101–10.
5. Mazur-Melewska K, Mania A, Kemnitz P, Figlerowicz M, Sluzewski W. Cat-scratch disease: a wide spectrum of clinical pictures. Postepy Dermatol Alergol. 2015;32(3):216–20.